Cart
sales@molnova.com
2-Ethyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridine
CAS No. 133240-06-9
2-Ethyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridine( —— )
Catalog No. M27437 CAS No. 133240-06-9
2-Ethyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridine is an adenosine receptor antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 50MG | 38 | In Stock |
|
| 100MG | 63 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 147 | In Stock |
|
| 1G | 220 | In Stock |
|
Biological Information
-
Product Name2-Ethyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridine
-
NoteResearch use only, not for human use.
-
Brief Description2-Ethyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridine is an adenosine receptor antagonist.
-
Description2-Ethyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridine is an adenosine receptor antagonist.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetAdenosine Receptor
-
Recptorc-Myc
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number133240-06-9
-
Formula Weight175.235
-
Molecular FormulaC10H13N3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCc1nc2c(C)cc(C)nc2[nH]1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Klongkumnuankarn P, et al. Cytotoxic and Antimigratory Activities of Phenolic Compounds from Dendrobium brymerianum. Evid Based Complement Alternat Med. 2015;2015:350410.
molnova catalog
related products
-
1-Ethyl-6-aminouraci...
1-Ethyl-6-aminouracil is an intermediate in the synthesis of a series of new substituted Xanthines which have high affinity and selectivity for the human adenosine A2B receptors.
-
Labetalol
Labetalol is a mixed alpha/beta-adrenergic antagonist.It is used to treat high blood pressure. It can be given by mouth for long term hypertension management or intravenously in severe hypertensive situations. The pharmacokinetics of labetalol is affected by the common CYP2C19 polymorphisms.
-
PSB 1115
PSB 1115 is an A2B receptor antagonist and can counteract the inhibitory effect of NECA.
